These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8243374)

  • 21. Felbamate pharmacology and use in epilepsy.
    Burdette DE; Sackellares JC
    Clin Neuropharmacol; 1994 Oct; 17(5):389-402. PubMed ID: 9316688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of felbamate in children with refractory epilepsy.
    Heyman E; Levin N; Lahat E; Epstein O; Gandelman-Marton R
    Eur J Paediatr Neurol; 2014 Nov; 18(6):658-62. PubMed ID: 24906615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticonvulsant activity of felbamate in amygdala kindling model of temporal lobe epilepsy in rats.
    Wlaź P; Löscher W
    Epilepsia; 1997 Nov; 38(11):1167-72. PubMed ID: 9579916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Felbamate as an add-on therapy for refractory epilepsy.
    Shi LL; Dong J; Ni H; Geng J; Wu T
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008295. PubMed ID: 21249704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Felbamate therapy in the Lennox-Gastaut syndrome.
    Snodgrass SR
    N Engl J Med; 1993 Jun; 328(22):1641. PubMed ID: 8487814
    [No Abstract]   [Full Text] [Related]  

  • 26. Isobolographic and subthreshold analysis of interactions among felbamate and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice.
    Borowicz KK; Luszczki JJ; Czuczwar SJ
    Epilepsia; 2004 Oct; 45(10):1176-83. PubMed ID: 15461671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Felbamate: a long-term study in subjects with refractory epilepsy].
    De Romanis F; Sopranzi N
    Clin Ter; 1997 Mar; 148(3):83-7. PubMed ID: 9377844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term use of felbamate: clinical outcomes and effect of age and concomitant antiepileptic drug use on its clearance.
    White JR; Leppik IE; Beattie JL; Walczak TS; Tran TA; Rarick JO; Vaher P
    Epilepsia; 2009 Nov; 50(11):2390-6. PubMed ID: 19563346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Felbamate.
    Leppik IE
    Epilepsia; 1995; 36 Suppl 2():S66-72. PubMed ID: 8784215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience.
    Shah YD; Singh K; Friedman D; Devinsky O; Kothare SV
    Epilepsy Behav; 2016 Mar; 56():50-3. PubMed ID: 26828692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
    Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL
    Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of felbamate on plasma levels of carbamazepine and its metabolites.
    Albani F; Theodore WH; Washington P; Devinsky O; Bromfield E; Porter RJ; Nice FJ
    Epilepsia; 1991; 32(1):130-2. PubMed ID: 1985822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate.
    Wagner ML; Graves NM; Marienau K; Holmes GB; Remmel RP; Leppik IE
    Epilepsia; 1991; 32(3):398-406. PubMed ID: 1904346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of felbamate in therapy for partial epilepsy in children.
    Carmant L; Holmes GL; Sawyer S; Rifai N; Anderson J; Mikati MA
    J Pediatr; 1994 Sep; 125(3):481-6. PubMed ID: 8071763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome.
    Glauser T; Kluger G; Sachdeo R; Krauss G; Perdomo C; Arroyo S
    Neurology; 2008 May; 70(21):1950-8. PubMed ID: 18401024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Felbamate: perspectives for new antiepileptic treatment].
    Pérez-Miranda J; Aguirre J; Parrilla JL; Pérez Miranda M
    Rev Neurol; 1995; 23(124):1220-5. PubMed ID: 8556622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Felbamate levels in patients with epilepsy.
    Harden CL; Trifiletti R; Kutt H
    Epilepsia; 1996 Mar; 37(3):280-3. PubMed ID: 8598188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Felbamate for partial seizures: results of a controlled clinical trial.
    Leppik IE; Dreifuss FE; Pledger GW; Graves NM; Santilli N; Drury I; Tsay JY; Jacobs MP; Bertram E; Cereghino JJ
    Neurology; 1991 Nov; 41(11):1785-9. PubMed ID: 1944909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rufinamide for the treatment of Lennox-Gastaut syndrome.
    Besag FM
    Expert Opin Pharmacother; 2011 Apr; 12(5):801-6. PubMed ID: 21348771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures.
    Bourgeois B; Leppik IE; Sackellares JC; Laxer K; Lesser R; Messenheimer JA; Kramer LD; Kamin M; Rosenberg A
    Neurology; 1993 Apr; 43(4):693-6. PubMed ID: 8469324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.